Intuitive Surgical, Inc. (ISRG) is well poised for growth in the coming quarters, courtesy of its strength in robotics. The optimism, led by solid 2023 results and its progress on the artificial intelligence (AI) front, is expected to contribute further. Risks pertaining to procedure adoption and stiff competition persist.Shares of this currently Zacks Rank #3 (Hold) company have risen 38.4% in the past year against the industry’s 0.1% decline. The S&P 500 Index has gained 20.6% during the same time frame.I ...

The most recent trading session ended with Intuitive Surgical, Inc. (ISRG) standing at $362.33, reflecting a -0.38% shift from the previouse trading day's closing. This change lagged the S&P 500's 0.37% loss on the day. Elsewhere, the Dow saw a downswing of 0.62%, while the tech-heavy Nasdaq depreciated by 0.19%.Coming into today, shares of the company had gained 10.74% in the past month. In that same time, the Medical sector gained 4.61%, while the S&P 500 gained 1.56%.The upcoming earnings release of Intu ...

Intuitive Surgical, Inc. (ISRG) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be release ...

Investors are always looking for stocks that are poised to beat at earnings season and Intuitive Surgical, Inc. (ISRG) , may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Intuitive Surgical is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — ...

Despite ongoing concerns about a rich valuation, shares of healthcare robotics and artificial intelligence (AI) stock Intuitive Surgical (ISRG 0.39%) had a stellar 2023. In fact, management just provided preliminary fourth-quarter 2023 earnings, as well as a first look at expectations for 2024, and investors were pleased. Intuitive stock just hit fresh all-time highs, and rallied nearly 40% over the last 12-month stretch. The company believes it has ample opportunities left to address critical issues in hea ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Intuitive Surgical, Inc. (ISRG) , which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider.This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 5.56%.For the most recent quarter, Intuitive Surgic ...

Core Insights - Intuitive Surgical (ISRG) reported strong preliminary revenue results for Q4 2023, with net sales estimated at least $1.93 billion, reflecting a 17% year-over-year increase [1] - The company anticipates full-year revenues of $7.12 billion for 2023, indicating a 14% year-over-year growth [2] Revenue Performance - Q4 2023 net sales are projected at $1.93 billion, surpassing the Zacks Consensus Estimate of $1.86 billion [1] - Sales from instruments and accessories reached $1.14 billion, marking a 22% year-over-year growth, driven by increased da Vinci procedure volume and higher pricing [1] - Full-year revenues from instruments and accessories were $4.28 billion, up 22%, while systems revenue remained flat at $1.68 billion [2] Procedure Volume and System Placements - Da Vinci procedures grew approximately 21% worldwide in Q4 2023, benefiting from a favorable comparison to the previous year when COVID-19 impacted volumes [2] - The company placed 415 da Vinci systems in Q4 2023, reflecting a 12% year-over-year increase, which is expected to support continued growth in procedure volumes in 2024 [2][3] Market Recovery - The company completed about 2,286,000 surgical procedures with da Vinci systems in 2023, a 22% increase from 2022, attributed to improved market conditions, particularly in general surgery and cancer procedures [3] - COVID-19 disruptions were minimal in the second half of 2023, leading to a recovery in procedure volumes, particularly in China [4] Stock Performance - ISRG shares rose 15.4% from October 1 to December 31, 2023, outperforming the industry growth of 10.1% and the S&P 500's 10.6% increase during the same period [5]

Another healthy day for market indices today is always a welcome sight. We’re operating with little data to this stage in the week, but we won’t turn our nose up at modest bullish sentiment. The Dow was just off session highs, +170 points, +0.45%, while the S&P 500 moved back above 4780: +0.57%. Both are a smidge off all-time highs reached just last week. The Nasdaq outperformed the field, +111 points, +0.75% and riding a four-day winning streak, while the small-cap Russell 2000 took a breather today, -0.24 ...

Key TakeawaysThe S&P 500 gained 0.6% on Wednesday, Jan. 10, 2024, ahead of inflation data and bank earnings later in the week.Intuitive Surgical shares surged after it beat revenue estimates on increased usage of its da Vinci robotic surgical system.Capital One Financial fell after a BMO downgrade on concerns over charge-offs for uncollected debt.The S&P 500 posted a gain of 0.6% on Wednesday ahead of key inflation data and bank earnings due later in the week. The Nasdaq rose 0.8%, while the Dow moved highe ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) JPMorgan Healthcare Conference Call January 10, 2024 12:00 PM ET Company Participants Gary Guthart - CEO & Director Brian King - Head, IR Jamie Samath - SVP & CFO Conference Call Participants Robert Marcus - JPMorgan Chase & Co. Robert Marcus Good morning, everyone. Happy to continue day 3 of the JPMorgan Healthcare Conference. I'm Robbie Marcus, the Medtech Analyst. Really pleased to introduce our next session. CEO of Intuitive Surgical, Gary Guthart, will do a quick ...